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ABSTRACT 
Periodontium consists of gingiva, alveolar mucosa, alveolar bone, cementum and 
periodontal ligament (PDL). PERIOSTIN, which is expressed in fibroblastic cells 
in PDL and in osteoblastic cells on the alveolar bone surface, is a key 
extracellular matrix protein that maintains homeostasis of periodontal tissue. 
During the process for FAM20C protein purification, we discovered that 
PERIOSTIN is co-purified with FAM20C. Immunolocalization of both FAM20C 
and PERIOSTIN were observed in the PDL extracellular matrix of murine 
periodontal tissues. PERIOSTIN bound with FAM20C in vitro. We further 
identified the binding domain of FAM20C in PERIOSTIN, which mapped within 
Fasciclin (FAS) I domain 1-4 (RD 1-4) of PERIOSTIN. PERIOSTIN has four 
conserved S-X-E motifs in both human and mouse FAS domain, which allowed 
us to use the murine model determine whether PERIOSTIN is phosphorylated by 
FAM20C and whether this phosphorylation might contribute to the integrity of 
periodontium tissues. 
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1. Introduction 
 
1.1 Periodontium 
     The periodontium consists of root cementum, periodontal ligament, bone lining 
the tooth socket (alveolar bone), and a part of the gingiva facing the tooth 
(dentogingival junction) defined as those tissues supporting and investing the 
tooth (CHO & GARANT, 2000; NANCI & BOSSHARDT, 2006). 
 
Dentogingival junction  
     The dentogingival junction, gingiva facing the tooth, is an adaptation of the 
oral mucosa that contains epithelial and connective tissue components. There 
are three functional compartments- gingival, sulcular, and junctional epithelium 
(CHO & GARANT, 2000; NANCI & BOSSHARDT, 2006).  
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Illustration 1. Structures of dentogingival junction. There are three main 
components of dentogingival junction: (1) free gingiva and attached gingiva, (2) 
gingival sulcus, (3) juctional epithelium (JE). 
      
     The function of junctional epithelium is to seal off periodontal tissues from the 
oral environment. Its integrity is thus essential for maintaining a healthy 
periodontium. Periodontal disease sets in when the sealing fails. The junctional 
epithelium originates from the reduced enamel epithelium when the tooth erupts 
into the oral cavity. Structurally, the junctional epithelium is a nondifferentiated, 
stratified squamous epithelium with a very high turnover. It is derived from a layer 
of cuboidal basal cells situated away from the tooth surface that rest on a 
basement membrane. The gingiva of the epithelial attachment, consists of a 
basal lamina-like structure that is adherent to the tooth surface and to which the 
superficial cell layer is attached by hemidesmosomes. Compared to gingival cells 
junctional epithelial cells contain more cytoplasm, rough endoplasmic reticulum, 
and Golgi bodies. They contain fewer tonofilaments and desmosomes, and have 
wider intercellular spaces. The latter fluid-filled spaces normally contain 
polymorphonuclear leukocytes, PMN and monocytes that penetrate the 
subepithelial connective tissue through the junctional epithelium and into the 
gingival sulcus. The PMNs and mononuclear cells and tissue fluid are the first 
line of defense to control the perpetual microbial challenge (CHO & GARANT, 
2000; NANCI & BOSSHARDT, 2006; Takei & Carranza, 2012).  
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Cementum 
     Cementum is the hard, avascular connective tissues that coats the roots of 
teeth and to which the principal periodontal ligament fibers attach. Based on the 
presence or absence of cementocytes it is classified as cellular or acellualr 
cementum. 
 Acellular fiber cementum Cellular fiber cementum 
Location Cervical  Apical and furcation 
Component Cells absent Cementocytes present  
Function Anchoring root to PDL Reshape the root 
Table 1. Comparison of two type of cementum (NANCI & BOSSHARDT, 
2006). 
 
     The composition of cementum is about 50% inorganic substances and 50% 
organic matrix. Type I collagen is the predominant organic component, 
constituting up to 90% of the organic matrix. Other collagens include type III, a 
less cross-linked collagen found in high concentrations during development and 
repair ⁄ regeneration of mineralized tissues, and type XII which binds to type I 
collagen and also to non-collagenous matrix proteins. In mature cementum, type 
V, VI, and XIV collagens are found in trace amounts.(Bosshardt, 2005; CHO & 
GARANT, 2000; NANCI & BOSSHARDT, 2006). 
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Alveolar bone  
    There are three parts to jaw alveolar processes. The outer cortical plates 
(buccal, lingual, and palatal) of compact bone are the first. Second is the central 
spongiosa. Third is bone lining the alveolus. The cortical plate and bone lining 
the alveolus meet at the alveolar crest. Bone lining the socket provides 
attachment for the periodontal ligament fiber bundles and is referred to as bundle 
bone (NANCI & BOSSHARDT, 2006). The non-collagenous composition of 
alveolar bone include type I and III collagens and polypeptides including bone 
sialoprotein and osteopontin (BARTOLD & Narayanan, 2006). 
Periodontal ligament  
     The periodontal ligament is a soft, specialized connective tissue between the 
cementum covering the root of the tooth and the bone forming the socket wall. 
The width ranges from 0.15 to 0.38 mm, with its thinnest portion around the 
middle third of the root. It shows a progressive decrease in thickness with 
increasing age. It supports the teeth in their sockets and permits them to resist 
the forces generated by mastication. The periodontal ligament also has the 
capacity to act as a sensory receptor and modurates tissue homeostasis and 
repair ⁄ regeneration (CHO & GARANT, 2000; NANCI & BOSSHARDT, 2006). 
     The periodontal ligament has a very high turnover rate. It is a fibrous tissue 
containing collagen type I, III, V, VI, and XII. The ligament also contains 
proteoglycans, including versican, decorin and biglycan (BARTOLD & Narayanan, 
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2006). Furthermore, it has been shown that PDL cells have the capacity to 
differentiate into osteoblasts and cementoblasts (Chien, Lin, & Cho, 1999). 
    The cells in periodontal ligament regulate the extent of demineralization and 
prevent ankylosis. Bone sialoprotein and osteopontin may play important roles in 
balancing this status. Matrix ‘Gla’ protein acts as an inhibitor of mineralization 
and is also present in periodontal tissues which may also act to preserve the 
periodontal ligament width. At the molecular level, it has been reported that Msx2 
prevents the osteogenic differentiation of periodontal ligament fibroblasts by 
repressing Runx2 transcriptional activity (Yoshizawa et al., 2004). It has also 
been reported that glycosaminoglycans or RGD–cementum attachment protein 
may also play a role in maintaining the unmineralized state (J, SJ, RC, WA, & C, 
1995; Ohno et al., 2002). Currently, further study is needed to determine how the 
periodontal ligament remains unmineralized.  
 
1.2 PERIOSTIN 
    PERIOSTIN was first known as osteoblast-specific factor 2, but was renamed 
based on the expression patterns specific to periosteum and PDL. A potential 
function of PERIOSTIN is to act as a cell adhesion molecule for preosteoblasts 
and to induce osteoblast attachment and spreading (Horiuchi et al., 1999). In 
humans, the PERIOSTIN gene is located on chromosome 13 at map position 
13q13.3. The gene product has 835 amino acids (Hamilton, 2008). PERIOSTIN 
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(POSTIN) is a 90-kDa secreted protein that has several domains composed of an 
amino-terminal EMI domain, tandem repeats of 4 Fas I domains, and a carboxyl-
terminal region (CTR) including a heparin-binding site at its C-terminal end. 
Based on these typical Fas I domains, POSTIN is classified as a member of the 
fasciclin I family. Fasciclin I is a GPI-anchored Drosophila protein containing 4 
tandem Fas I domains composed of about 150 amino acid residues each. They 
are not related to any other protein domain of known structures. It functions in 
guidance of axon growth [8]. It is reported that PERIOSTIN directly interacts with 
Type I collagen, FIBRONECTIN and NOTCH1 through its EMI domain, while 
TENASCIN-C and BMP-1 through its Fas I domains (Kii et al., 2006; 2010; 
Maruhashi, Kii, Saito, & Kudo, 2010; Norris et al., 2007; G. Takayama et al., 
2006; Tanabe et al., 2010).  
 
Illustration 2. Structure of PERIOSTIN. PERIOSTIN is a 90-KDa secreted 
protein, induced by TGFβ. The protein structure contains an amino-terminal EMI 
domain, a tandem 4 repeat of Fas1 domains, and a carboxyl-terminal domain 
CTR (I. Takayama & Kudo, 2012). 
 
     POSTN is highly expressed in collagen-rich connective tissues. It has been 
shown to be associated with various tissues and pathologies including bone, 
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PDLs, skin, cardiac valves, muscle injury, vascular injury, myocardial infarction, 
epithelial ovarian cancer, colorectal cancer, pulmonary vascular remodeling, 
bronchial asthma, and oral cancer.  
     PERIOSTIN functions in cardiac repair, tumorigenesis, and obesity. In cardiac 
repair, PERIOSTIN plays an important role in the development of the embryonic 
heart by increasing collagen fibrillogenesis and compaction. With regard to 
tumorigenesis, PERIOSTIN plays a role in tumor development and metastasis. 
The Fas 1–2 domain involved in cell adhesion facilitates tumor growth and 
angiogenesis. In obesity, PERIOSTIN is highly expressed in adipose tissue 
suggesting a role in repair or expansion of adipose tissue (Romanos, Asnani, 
Hingorani, & Deshmukh, 2013).  
     In this report, I will focus on possible functions of PERIOSTIN in the 
periodontium. 
     PERIOSTIN helps to maintain tissue integrity by enhancing the proteolytic 
activation of lysyl oxidase (LOX) which is responsible for collagen cross-link 
formation. It thus determines the diameter of collagen fibrils to give different 
tissue strength. (Kudo, 2011; Romanos et al., 2013) Mechanical loading has a 
positive relationship to bone growth and development. Under occlusional stress, 
PERIOSTIN stimulates osteoblast adhesion, differentiation, and survival through 
the FAK signaling pathway and suppresses the action of sclerostin by osteocytes 
(Horiuchi et al., 1999; Romanos et al., 2013; I. Takayama & Kudo, 2012). PDL 
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plays a role in transmission of masticatory force. PERIOSTIN expression level in 
PDL is proportionally up-regulated with mechanical stress (Kii et al., 2006; 
Romanos et al., 2013). These findings suggest that PERIOSTIN has effects on 
the formation of the meshwork structure of the PDL fibers and consequent 
changes in periodontal structures. 
 
1.3 FAM20C 
     FAM20C, also known as ‘‘dentin matrix protein 4’’ (DMP4) in mice, contains 
579 amino acids in the human form. There is a 26-amino acid signal peptide at 
the N-terminus and approximately 350 amino acids at C- terminal region (D. 
Nalbant, Youn, & Nalbant, 2005). FAM20C is highly expressed in the mineralized 
tissues; i.e. osteocytes, odontoblasts, ameloblasts, and cementoblasts, as well 
as in the dentin and enamel. The high expression level of FAM20C in these 
tissues suggests that it has an important role in the formation and mineralization 
of these tissues (Wang et al., 2010).  
     Golgi casein kinase (G-CK) was first described in lactating mammary glands. 
It is capable of enzymatically phosphorylating endogenous Casein (Bingham & 
Farrell, 1974). Recently, FAM20C was identified as the Golgi casein kinase. It 
phosphorylates secretory pathway proteins within Ser-X-Glu/phospho-Ser 
(SxE/pS) motifs, observed in the small integrin-binding ligand, N-linked 
glycoproteins (SIBLINGs) (Tagliabracci, Engel, Wen, & Wiley, 2012).  
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     In mammals, FAM20C is a member of the ‘‘family with sequence similarity 
20’’; consisting of three members: FAM20A, FAM20B and FAM20C (D. Nalbant 
et al., 2005). FAM20C is also known as a causative gene for Raine syndrome 
(Hao, Narayanan, Muni, Ramachandran, & George, 2007). Raine syndrome is an 
autosomal recessive disorder characterized by generalized osteosclerosis with 
periosteal bone formation and a distinctive facial phenotype (Ishikawa, Xu, Ogura, 
Manning, & Irvine, 2012; Kinoshita, Hori, Taguchi, & Fukumoto, 2014). FAM20C 
kinase activity is essential for limiting bone formation in humans. Since SIBLING 
proteins as FAM20C substrates can act as nucleaters or inhibitors of 
biomineralization, Raine syndrome’s feature could be explained by decreased 
phosphorylation of SIBLING proteins. To support this notion, it was been 
reported that ASARM peptide products inhibit mineralization by binding to 
hydroxyapatite in a phosphorylation-dependent manner. (Addison, Masica, Gray, 
& McKee, 2009; Ishikawa et al., 2012).  
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2. Objectives 
     Studies in our lab previously found that PERIOSTIN co-purified with FAM20C. 
FAM20C as Golgi casein kinase (GCK) has the ability to phosphorylate secretory 
proteins. Therefore, the purposes of the current study were to investigate 1) 
where PERIOSTIN and FAM20C are located within craniofacial tissues and 2) 
whether FAM20C can bind to PERIOSTIN either directly or indirectly, and 3) to 
further map the binding domain of FAM20C in PERIOSTIN. 
 
3. Materials and Methods 
3.1 Reagents and antibodies 
• Dulbecco's Modified Eagle Medium (DMEM) (1X), liquid (4.5 g/L D-
Glucose,L-Glutamine,110mg/L Sodium Pyruvate) was purchased from Life 
Technologies (Carlsbad, CA, USA).  
• Penicillin and streptomycin mixture was added to DMEM using Penicillin-
Streptomycin Solution, 100X, 10,000 I.U. Penicillin 10,000 µg/mL and 
Streptomycin purchased from Mediatech, Inc. (Manassas, VA., USA).  
• Fetal Bovine Serum, was purchased from Invitrogen (Carlsbad, CA, USA) 
and added to DMEM.  
• X-tremeGENE 9 DNA transfection reagent was purchased from Roche 
Applied Sciences, Indianapolis, IN, USA. 
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• Cells were detached from culture plates using Trypsin, 0.25% 1X, with 
2.5g porcine trypsin (1:250/L gamma irradiated) in HBSS with 1g/L EDTA, 
without calcium or magnesium purchased from Thermo Scientific 
(Waltham, MA, USA). 
• SDS NuPAGE® MOPS SDS Running Buffer (for Bis-Tris Gels only) (20X) 
was purchased from Invitrogen (Carlsbad, CA, USA).  
• NuPAGE® Novex 4-12% Bis-Tris Gel 1.0 mm, 12 well was purchased 
from Invitrogen (Carlsbad, CA, USA).  
• Immobilon-P Membrane purchased from Millipore (Billerica, MA, USA) 
was used to transfer Western blot gel.  
• Nonfat dry milk was purchased from Lab Scientific (Livingston, NJ, USA). 
• ECL™ Western Blotting Detection Reagents from GE Healthcare. 
• HyBlot CL autoradiography film was purchased from Denville Scientific 
Incorporation. 
• Western Blot Stripping Buffer was purchased from Thermo Scientific. 
• Lysis buffer was prepared containing 150mM NaCl, 20mM Tris-HCl 
(pH7.5), 10mM EDTA ,1% Triton-X 100 and 1% deoxycholate.  
• Transfer buffer was prepared containing 0.025M Tris-HCl, 0.192M glycine, 
and 20% methanol. 
• Tris-buffered saline was prepared (TBS) (1X) containing 20mM Tris (pH 
7.5) and 137mM NaCl. 
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• TBS-T was prepared contains 20 mM Tris (pH 7.5), 137 mM NaCl, and 
0.1% tween. 
• SDS-Sample buffer was prepared containing 100mM Tris-HCL (pH8.8), 
0.01% bromphenol blue, 36% glycerol and 4% SDS. 
• Recombinant mouse PERIOSTIN protein (2955-F2) was obtained from 
R&D Systems.  
• The antibodies used in this study were as follows; anti-V5 (Life 
Technologies), anti-HA (clone 12CA5, Roche Life Science), anti-HA high 
affinity (clone 3F10, Roche Life Science), and rabbit polyclonal anti-
PERIOSTIN (ab14041, Abcam) antibody.  
 
3.2 Plasmid construction 
 
    Human FAM20C expression vector constructs including wild-type (WT) and a 
mutant form lacking its kinase activity (D478A, {Tagliabracci, 2012 #213}) 
expression vector were generated by PCR methods. The plasmids containing the 
full length coding sequence for human FAM20C was purchased from Open 
Biosystems and used as a PCR template. The sequences of the primers were; 
(for FAM20C-WT) forward primer: 5’GCGGTACCGCCATGAAGATGATGCTGG-
3’ and reverse primer: 5’-GCCTCGAGCCTCGCCGAGGCGGCTCTG-3’, (for 
FAM20C-D478A) mutagenesis forward primer: 5’-
CACTTAGCCAATGGAAGAGGG-3’ and mutagenesis reverse primer: 5’-
CCCTCTTCCATTGGCTAAGTG-3’. The PCR products of each FAM20C form 
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were ligated into pcDNA3.1-V5/His mammalian expression vector, sequenced 
and the plasmids harboring FAM20C-WT and FAM20C-D478A cDNAs followed 
by V5/His- (pcDNA3.1-FAM20C-WT-V5/His and pcDNA3.1-FAM20C-D478A-
V5/His) were successfully generated. 
 
3.3 Cell culture 
     Human embryonic kidney HEK 293 cells purchased from Clontech (Mountain 
View, CA, USA) were maintained in DMEM containing a high concentration of 
glucose (4.5 mg/ml) supplemented with 10% FBS, and 100 units/ml of penicillin 
and 100 µg/ml of streptomycin in a 5% CO2 atmosphere at 37 oC. 
 
3.4 Transfection, Immunoprecipitation, and Western Blot Analysis 
     HEK 293 cells were plated onto 6-well culture plates at a concentration of 3 
x105 cells/well. On the following day, cells were transiently transfected in 
duplicate using X-treme GENE 9 DNA transfection reagent (Roche Applied 
Sciences, Indianapolis, IN, USA ) . After 24 hours of transfection, cells were 
lysed using the lysis buffer(150mM NaCl, 20mM Tris-HCl (pH7.5), 10mM EDTA 
,1% Triton-X 100 and 1% deoxycholate). Cell lysates were centrifuged and the 
supernatant collected.  Samples were incubated with SDS sample buffer for 5 
min. at room temperature and separated by SDS-polyacrylamide gel 
electrophoresis (SDS-PAGE) using NuPAGE® Novex® 4-12% Bis-Tris Gels. 
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Samples were transferred to Immobilon-P Membrane in transfer buffer using 
Mini-PROTEAN® Tetra Cell system at 30 volts and 0.04 ampere overnight. 
Western blot analysis was then performed as follows: the membrane was 
blocked with TBS (20 mM Tris-HCl, pH 7.5, 137 mM NaCl) containing 10% skim 
milk overnight at 4oC. The membrane was then washed 3 times with TBS and 
incubated with the respective antibody overnight at 4 oC. After washing the 
membrane 3 times with TBS the membrane was incubated with anti-HA, anti-V5 
or anti-PERIOSTIN antibody for one hour at room temperature. The membrane 
was again washed 5 times with TBS and visualized using ECL™ Western 
Blotting Detection Reagents. 
 
3.5 Binding of FAM20C to PERIOTIN 
     The 293 cells were plated onto 6 well culture plates at a density of 3 x 105 
cells / well and transfected with mouse periostin with C-terminal HA tag (pCAGI-
puro delta periostin (b-)-WT-HA; periostin -WT-HA) and FAM20C-WT-V5/His, 
FAM20C-D478A-V5/His, or FAM20C-P328S-V5/His. After 24 hours of 
transfection cell lysates were collected, immunoprecipitated (IP) with anti-V5 
antibody and subjected to Western blotting (WB) analysis using anti-HA antibody 
to identify the binding. The same membrane was stripped by the stripping buffer 
(15g glycine, 1g SDS, 10ml Tween, and bring volume to 1L), and WB with anti-
V5 antibody was performed to verify the expression of FAM20C-V5/His proteins. 
An aliquot of the same cell lysates was subjected to WB analysis with anti-HA 
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antibody to verify the expression of PERIOSTIN-WT-HA. 
 
3.6 Purification of FAM20C proteins from cell lysates  
     Clones that overexpress FAM20C that were previously generated in our lab 
were grown on ten 15 cm culture plates. The cell pellets of FAM20C-WT and 
FAM20C-D478A were collected after trypsin treatment and stored at -20 °C until 
use. Forty ml of Native Binding Buffer (1x Native purification buffer) with protease 
inhibitors was used to resuspend cells from one 15cm dish. Cells were frozen at -
20 °C and thawed at room temperature for two cycles. Cells were then sheared 
by passing the preparation through 16-gauge needle four times. The cell lysates 
were centrifuged at 3,000 rpm for 15 min and the supernatant was transferred to 
new tubes. Ni-NTA agarose 400 µl was added to 40 ml of the clear supernatant 
and incubated overnight at 4 °C. After incubation, the lysates were poured into 
the columns and washed with 500 ml of Native Wash Buffer. Proteins were then 
eluted into 15 1ml fractions by Native Elution Buffer. Forty µl samples from each 
fraction were taken, mixed with SDS sample buffer, applied to SDS-PAGE, and 
positive fractions were identified by Western blotting with anti-V5 AP antibody. 
 
3.7 In vitro Binding assay 
     The mouse recombinant PERIOSTIN and FAM20C-WT-V5/His or FAM20C-
D478A-V5/His proteins were incubated in PBS. The total protein per sample was 
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kept constant by adding bovine serum albumin (BSA). Samples were then 
immunoprecipitated (IP) with anti-V5 antibody followed by Western blot (WB) 
analysis with anti-PERIOSTIN (Abcam) antibody. The same membrane was 
stripped and WB with anti-V5 antibody was used to verify the expression of 
FAM20C-V5/His proteins. 
 
3.8 Mapping of FAM20C-V5 binding domain to Periostin 
     Various deletion mutant forms of pCAGI-puro delta periostin (b-)-HA were a 
generous gift from Dr. Kudo’s laboratory (Japan). They were used to identify the 
interaction domain of periostin with Fam20C as previously described. The 
deletion forms; periostin -WT-HA, periostin delta CTR-HA lacking its C-terminal 
region, periostin delta EMI-HA lacking EMI domain, periostin delta EMI-CTR-HA 
lacking both EMI and CTR domains, and periostin EMI-HA (EMI domain only). 
Briefly, HEK 293 cells were transiently transfected with periostin -WT-HA, 
periostin -dCTR-HA, periostin -dEMI-HA, periostin -dEMI-CTR-HA, or periostin -
EMI-HA and FAM20C-WT-V5/His. After 24 hours of transfection, cell lysates 
were collected and the binding domain was identified by IP-WB analysis in the 
same manner as described above. 
 
3.9 In vitro kinase assay 
     Kinase assays were performed in 20µl reaction mixture containing with 1mM 
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cold ATP (Thermo Fisher), 50 mM Tris-HCl pH 7.0, 10 mM MnCl2, 12.5 µg/ml of 
recombinant POSTIN, 25 µg/ml of FAM20C-WT-V5/His, and 25 µg/ml of GST-
FAM20A. The mixtures were incubated for 30 min at 30 °C, then stopped by 
adding SDS sample buffer and boiling for 5min. Reaction products were 
separated by 4~12% SDS-PAGE and detected by Western-blotting.  
 
3.10 Phosphorylation analyses using Biotinylated phos-tag™ 
     As complex of Biotin-pendant Zn2︎-Phos-tag and HRP-conjugated Streptavidin 
HRP—10mg of BTL-104 was diluted with 0.13ml of methanol and 1.17ml of TBS-
T and stored in the dark at 4°C. The 4:1 complex of biotin-pendant Zn2+-Phos- 
tag™ and HRP was mixed with 10ul of Phos-tag™ BTL-104 solution, 1µl of 
Pierce peroxide conjugate(Thermo), 20µl of 10 mM Zn(NO3) 2 , and 469µl of 
TBS-T. The solution was allowed to stand for 30 min at room temperature. The 
mixed solution was put into a concentrator 30K filter unit Pierce and centrifuged 
for 20 min at 14,000µg to remove excess biotin-pendant Zn2+-Phos-tag. The 
remaining solution (<10 µl) in the reservoir was diluted with 30 ml of TBS-T 
solution and stored at 4 °C (Zn2+-Phos-tag-bound HRP solution). 
Probing with Zn2+-Phos-tag-bound HRP—A protein-blotted PVDF membrane 
was soaked in a TBS-T solution for at least 1 h. The membrane was incubated 
with the Zn2+-Phos-tag-bound HRP solution (1 ml/5 cm2) in a plastic bag for 30 
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min and washed twice with a TBS-T solution at room temperature. Proteins were 
detected by the ECL method. 
 
 
4. Results 
     PERIOSTIN was co-purified during the process of FAM20C protein 
purification suggesting that PERIOSTIN may bind to FMA20C. To confirm this 
notion, IHC using anti-PERIOSTIN and anti-FAM20C antibodies was performed 
on serial sections of mouse maxillary tissues. Both FAM20C (Fig.1 b, c; indicated 
by black arrows) and PERIOSITIN (Fig.1 f, g; indicated by filled arrows) were 
identified in PDL. In sections, FAM20C was also present in dentin-enamel 
junction (Fig.1 d; arrowheads) and alveolar bone (Fig.1 b, c; open arrows) where 
PERIOSTIN was not shown. No immunoreactivities were detected when non-
immune Ig was used (Fig.1 i-p). 
 
Binding of FAM20C to PERIOSTIN 
     To verify the interaction between FAM20C and POSTIN and investigate 
whether this interaction requires FAM20C’s kinase activity, an inactive kinase 
form of FAM20C (D478A) and a Raine-syndrome mutation form (P328S) in 
addition to FAM20C -WT were used for the binding assay. HEK 293 cells were 
transiently transfected with Periostin-WT-HA and FAM20C-WT-V5/His, FAM20C-
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D478A-V5/His, or FAM20C-P328S-V5/His. Immunoprecipitation and Western 
blot analysis demonstrated that FAM20C -WT interacted with Periostin-WT (Fig. 
2A upper panel, lane 3). Both inactive kinase forms of FAM20C, i.e. D478A and 
P328S, also bound to Periostin indicating that the interaction between Fam20c 
and Periostin does not require FAM20C’s kinase activity (Fig. 2A, upper panel, 
lanes 4 and 5). The expression of each FAM20C form was similar (Fig. 2A, lower 
panel, lanes 3-5). 
To determine whether the binding between FAM20C and PERIOSTIN is direct, 
recombinant PERIOSTIN protein produced by Sf21 baculovirus and FAM20C-
WT-V5/His or FAM20C-D478A-V5/His protein purified from the HEK 293-
conditioned media were immunoprecipitated (IP) with anti-V5 antibody. Western 
blot analysis with anti-PERIOSTIN antibody showed that FAM20C-D478A, but 
not WT interacted with PERIOSTIN (Fig. 2B, lower panel, lanes 4 and 5). 
 
Mapping of FAM20C-binding domain in PERIOSTIN 
    Immunoprecipitation (IP)-Western blotting (WB) analysis using various forms 
of periositn-HA vectors and FAM20C-V5 was used to identify the binding domain 
between FAM20C and PERIOSTIN. In samples where both Periostin-HA and 
Fam20c-V5 were co-expressed (Fig 3. lane 3, 5, 7, and 9), immunoreactive 
bands to anti-HA antibody were presented after IP with anti-V5 antibody but not 
with Periostin-dEMI-HA. The expression of Periostin-HA was confirmed by IP-
Western blotting with anti-HA antibody (Fig. 3, middle panel, lanes 2~11). The 
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expression of FAM20C -WT was confirmed by Western blotting with anti-V5 
antibody (Fig. 3, lower panel, lanes 3, 5, 7, 9 and11). The data demonstrated that 
Periostin-HA, Periostin dCTR-HA, Periostin dEMI-HA, and Periostin dEMI-CTR-
HA bound to Fam20c.Periostin-EMI-HA did not bind to Fam20c-V5 (Fig. 3, upper 
panel, lane11).	If there were a band between FAM20C-WT and EMI, the 
immunoreactive band would be detected at the position indicated by the open 
arrowhead. However this reactivity was not detected.	The data indicate that 
Periostin-Fas domain is likely the binding domain of Fam20c-V5 in HEK 293 
cells. 
 
Phosphorylation of PERIOSTIN by FAM20C 
     PERIOSTIN is a secretory protein predominantly expressed in collagen-rich 
fibrous connective tissue. It has several S-X-E motifs in the protein sequence, 
suggesting that FAM20C phosphorylates PERIOSTIN. Therefore, we 
investigated whether FAM20C phosphorylates PERIOSTIN. FAM20A increases 
potentiates FAM20C kinase activity and phosphorylation ability. HEK 293 cell 
were transiently transfected with FAM20A-HA, FAM20C-WT-V5 and a kinase 
inactive form of FAM20C (D478A). Cell lysates were collected, 
immunoprecipitated with anti-V5 antibody and protein A-sepharose beads were 
added. The in vitro kinase assay was performed with the collected protein 
complex with anti-V5 antibody and recombinant PERIOSTIN protein produced by 
Sf21 baculovirus. The level of POSTIN was confirmed by WB using anti-
periostin. The expression of FAM20C was confirmed by WB using anti-V5 
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antibody. To analyze phosphorylation of PERIOSTIN, biotinylated phos-tag was 
used. The phos-tag method recombinant FAM20C (Rec. FAM20C; Fig. 4 lane 6)  
detected recombinant FAM20C (Rec. FAM20C; Fig. 4 lane 6) by WB with phos-
tag, suggesting that FAM20C was phosphorylated. No expression of PERIOSTIN 
phosphorylation was detected using the pho-tag method. (Fig. 4 lane 1~5). 
 
Secretion of PERIOSTIN 
     To determine whether FAM20C helps PERIOSTIN secretion, HEK 293 cells 
were transiently transfected with Periostin-WT-HA and Fam20c-WT-V5/His or 
Fam20c-D478A-V5/His. After 12 hours, the conditioned medias were collected 
and analyzed by Immunoprecipitation (IP)-Western blots. Cell lysates were also 
collected and the expression of PERIOSTIN was confirmed by Western blotting 
with anti-HA antibody (Fig. 5, upper panel, lanes 2-4). The expression of 
Fam20c-V5 was confirmed by Western blotting with anti-V5 antibody (Fig. 5, 
middle panel, lanes 3 and 4). The bands in the lower panel showed the 
expression of PERIOSTIN. With Fam20c-WT-V5 is similar to PERIOSTIN only 
(Fig. 5 lane 2 and 3). Fam20c-D478A-V5 expression was weak compared to the 
previous two lanes (Fig 5. Lane 2, 3, and 4). The results indicate that there is no 
obvious relationship between PERIOSTIN secretion and FAM20C. Lanes 2, 3 
and 4 showed thick bands where they were expected to display two bands with 
one at the same level as lane1 and one at a lower level. The overlapping thick 
bands may due to excessive exposure. 
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5. Discussion 
Binding of FAM20C to PERIOSTIN 
    Our studies recently showed that PERIOSTIN is one of the direct binding 
partners of FAM20C. We have used the FAM20C-WT and FAM20C-D478A, and 
FAM20C- P238S proteins to differentiate kinase-dependent and kinase-
independent binding proteins. FAM20C-D478A and FAM20C-P238S are the 
mutants of FMA20C. FAM20C-D478A is an artificially created kinase-dead 
mutant and FAM20C-P238S has decreased or impaired kinase activity (Kinoshita 
et al., 2014). In this study, it was shown that FAM20C interacted with 
PERIOSTIN in cell culture using HEK293 cell and in vitro using purified proteins. 
In cells PERIOSTIN was transfected with a kinase inactive form of FAM20C 
(D478A) and a Raine syndrome mutation form (P328S) to determine if the kinase 
activity is necessary for the interaction between FAM20C and PERIOSTIN. The 
results demonstrated that FAM20C-WT interacted with PERIOSTIN. Both kinase 
inactive forms of FAM20C, i.e. D478A and P328S, also bound to PERIOSTIN, 
indicating that the interaction of kinase activity between FAM20C and 
PERIOSTIN was not necessary (Fig. 2A). However, in vitro, the binding between 
FAM20C-WT with PERIOSTIN was below the detection level, though FAM20C-
DA bound to PERIOSTIN (Fig. 2B). At this point, it is uncertain why PERIOSTIN 
directly binds to a kinase-inactive form, but not WT of FAM20C. A recent study 
mentioned that the kinase does not always stably associate with its 
corresponding substrate because the biochemical phosphorylation reaction is 
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transient and reduces substrate detection (Ohyama et al., 2016). It is assumed 
that FAM20C-D478A lacks the kinase activity so that its substrates could not be 
phosphorylated and retained with FAM20C-D478A.  
 
Mapping binding domain 
     Based on the FAM20C and PERIOSTIN binding experiment, we further 
identified the binding site of PERIOSTIN to determine the function of binding. 
    Our binding assays used PERIOSTIN-HA, PERIOSTIN dCTR-HA, 
PERIOSTIN dEMI-HA, PERIOSTIN dEMI-CTR-HA, and EMI-HA with FAM20C-
WT. The results showed PERIOSTIN-HA, PERIOSTIN dCTR-HA, PERIOSTIN 
dEMI-HA, PERIOSTIN dEMI -CTR-HA bound to FAM20C but not to EMI-HA 
which indicated that the Fasciclin (Fas) domain in PERIOSTIN is necessary for 
binding of FAM20C (Fig.3). The S-X-E motif sites in PERIOSTIN might be 
phosphorylated by FAM20C. There are four S-X-E motif sites in mouse 
PERIOSTIN and three of these S-X-E motif sites are conserved in human 
PERIOSTIN (Fig.6). 
     FAM20C appears to be the Golgi casein kinase (G-CK) that phosphorylates 
secretory pathway proteins. The G-CK recognizes the consensus S-X-E/pS motif 
where X is any amino acid and E/pS can be Glu or phospho-serine (Ishikawa et 
al., 2012; Tagliabracci et al., 2012). Secretory calcium binding phosphoprotein 
(SCPP) members whose genes cluster on Chromosome 4 in humans, have 
multiple S-X-E/pS motifs and are phosphorylated by FMA20C (Kawasaki & 
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Weiss, 2003; Kinoshita et al., 2014). Analysis of the amino acid sequence of 
human, PERIOSTIN showed 3 probable FAM20C phosphorylation sites which 
are located in Fas I and Fas IV domain [Fig. 6A] (Coutu et al, JBC, 2008). The 
periostin isoform in mice has 4 potential phosphorylation sites which are in Fas I, 
Fas IV and CTR [Fig. 6B]. Since the binding sites are located in Fas domains, 
phosphorylation has high probability of occurring in Fas I and IV domains. Our 
next goal is to determine whether the binding reaction in Fas domains is related 
to phosphorylation. 
 
Phosphorylation of PERIOSTIN by FAM20C 
     To determine whether PERIOSTIN is phosphorylated by FAM20C, FAM20A 
and FAM20C were co-expressed in cultured HEK293 cell with PERIOSTIN and 
analyzed by an in vitro kinase assay. To further investigate phosphorylation 
activity, Western-blot analysis with biotinylated phos-tag was used to detect 
whether PERIOSTIN be phosphorylated or not. 
Protein phosphorylation, a fundamental mechanism that regulates many cellular 
function, was discovered in 1883 (Tagliabracci et al., 2012). Several 
phosphoproteins have been implicated in regulating biomineralization, including 
Small Intergrin-Binding Ligand N-linked Glycoproteins (SIBLING) (Ishikawa et al., 
2012). The common feature of SIBLING family members is the presence of S-X-
E motifs in their amino acid sequences, which are often phosphorylated (Fisher, 
Torchia, Fohr, Young, & Fedarko, 2001; Qin, Baba, & Butler, 2004). FAM20C 
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phosphorylates serine residues within the S-X-E motifs of OPN and DMP1. Thus 
FAM20C is a protein kinase that phosphorylates extracellular proteins (Ishikawa 
et al., 2012; Tagliabracci et al., 2012). 
     PERIOSTIN, the ECM protein is highly expressed in the PDL [Fig.1.]  and is a 
key factor required for periodontal integrity and hemostasis under normal 
occlusal load (Padial-Molina, Volk, & Rios, 2013; Rios et al., 2008). It is 
associated with cell proliferation, migration and activation of the survival signaling 
pathway PI3/AKT/mTOR (Padial-Molina et al., 2013). PERIOSTIN with several S-
X-E motifs located within Fas domains is one of potential candidate substrates of 
FAM20C.  
     We did not detect phosphorylation of PERIOSTIN using biotinylated phos-tag. 
[Fig.4.]. Rec. FAM20C was used as a positive control which autophosphorylated 
the protein. Phosphorylation of Rec. FAM20C with biotinylated phos-tag was 
detected confirming the validity of this method (Fig.4, lane 6). This under-
detection might be caused by defeat of kinase assay or insufficient concentration 
of phosphorylated PERIOSTIN could not be expressed by phos-tag. 
     This study confirmed that the FAM20C and PERISOTIN binding location is 
within the FAS domain which contained S-X-E motifs. FAM20C is a secreted 
protein kinase that preferentially phosphorylates the peptides containing S-X-E 
motifs. Further studies are required to verify that PERIOSITN may be 
phosphorylated by FAM20C and that phosphorylation may regulate cell functions 
such as biomineralization of extracellular matrix where PERIOSTIN is located.  
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Figure 1 
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Figure 1 (Cont.) 
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Figure legends 
Fig. 1. Localization of FAM20C and PERIOSTIN in mouse periodontium. 
Serial sections of mouse maxillary regions were stained using anti-FAM20C (a-d) 
or anti-PERIOSTIN (e-h) antibody. Non-immune goat Ig was also used as a 
negative control for anti-FAM20C (i-l) and non-immune rabbit Ig as a negative 
control for anti-PERIOSTIN (m-p). Panels (b-d), (f-h), (j-l) or (n-p) show higher 
magnification views of the open boxed areas in (a), (e), (i) or (m), respectively. 
The white boxed areas in (b) and (f) are further magnified and shown at the lower 
right corner of (b) and (f). Immunolocalization for FAM20C (brown color) is 
present in PDL (b, c; indicated by black arrows), dentin-enamel junction (d; 
arrowheads) and alveolar bone (c; indicated by open arrows). FAM20C is also 
observed in the PDL fibroblasts (b, c), dentinal tubules within odontoblasts (d; 
indicated by od) and osteoblasts (c; indicated by ob). 
Note that PERIOSTIN is present (brown color) in PDL (f, g; filled arrows) with 
strong positive signals along the thick PDL collagen (f), but not observed in 
dentin/odontoblasts (h). No immunoreactivities were detected when non-immune 
Ig was used (i-p). Scale bar; 200 µm (a, e, i, m), 100 µm (b-d, f-h, j-l, n-p). 
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Figure 2 
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Fig. 2. Binding of FAM20C to PEIOSTIN. (A) FAM20C binds to PERIOSTIN 
(POSTIN) in cell cultures. HEK 293 cells were transiently transfected with 
periostin-WT-HA and Fam20c-WT-V5/His, Fam20c -D478A-V5/His, or Fam20c 
P328S-V5/His. The cell lysates were collected, and immunoprecipitation (IP)-
Western blot (WB) analyses were performed. The binding of PERIOSTIN to 
Fam20c -WT (upper panel, lane 3), -D478A (upper panel, lane 4), or -P328S 
(upper panel, lane 5) was observed, indicating that this interaction didn’t require 
FAM20C kinase activity. (B) Direct binding of FAM20C to PERIOSTIN. FAM20C 
and POSTIN proteins were incubated in vitro, immunoprecipitated with anti-V5 
antibody, and subjected to WB analysis with anti-POSTIN antibody. FAM20C-
D478A directly interacted with PERIOSTIN but no in FAM20C-WT (lane 2 and 3) 
in vitro. 
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Figure 3 
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Fig. 3. Fasciclin domain in PERIOSTIN is the FAM20C-binding region. HEK 
293 cells were transfected with Periostin-WT-HA, Periostin-dCTR-HA, Periostin-
dEMI-HA, Periostin -dEMI-CTR-HA, or Periostin-EMI-HA and FAM20C-WT-
V5/His. The “d” indicates lacking the following domain; for example, dCTR is a 
form of Periostin lacking the CTR region. The binding between POSTIN and 
FAM20C was investigated using cell lysates by immunoprecipitation (IP) - 
Western blotting (WB) analysis. The result showed that FAM20C interacted with 
Periostin-WT-HA (upper panel, lane 3, indicated by an arrowhead), Periostin-
dCTR-HA (upper panel, lane 5, indicated by an arrowhead), Periostin -dEMI-HA 
(upper panel, lane 7, indicated by an arrowhead), and Periostin -dEMI-CTR-HA 
(upper panel, lane 9, indicated by an arrowhead), but not with Periostin -EMI-HA 
(upper panel, lane 11, indicated by an open arrowhead). The expression of all 
Periostin-HA constructs in the same cell lysate was confirmed by WB using anti-
HA antibody (middle panel) and the level of immunoprecipitated FAM20C was 
confirmed by WB using anti-V5 antibody (lower panel). An asterisk indicates a 
non-specific band (upper and middle panels). 
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Figure 4 
 
 
 
Fig. 4. Phosphorylation of PERIOSTIN by FAM20C. HEK 293 cells were 
transiently transfected with Fam20a-HA, Fam20c-WT-V5/His, and Fam20c-
D478A-V5/His. The cell lysates were collected, and kinase assays were 
performed with FAM20C and POSTIN proteins in vitro. Samples were then 
subjected to Western blot (WB) analysis. The result showed that only FAM20C 
be detected by phos-tag (upper panel lane 6). The level of POSTIN was 
confirmed by WB using anti-periostin (middle panel), and the expression of 
FAM20C in the same cell lysate was confirmed by WB using anti-V5 antibody 
(lower panel). The phos-tag method was confirmed by Rec. FAM20C (upper 
panel lane 6). 
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Figure 5 
 
 
 
Fig. 5. Secretion of PERIOSTIN. HEK 293 cells were transfected with periostin-
WT-HA, Fam20c-WT-V5/His, and Fam20c--D478A-V5/His. Conditioned media 
were collected and immunoprecipitated (IP) with anti-HA followed by Western 
blot (WB) analysis. The data showed that there was no obvious difference 
between whether Fam20c--WT or Fam20c--DA (lower panel) means FAM20C 
cannot help PERIOSTIN for secretion. The level of PERIOSTIN was confirmed 
by WB using anti-HA (upper panel), and the expression of FAM20C was 
confirmed by WB using anti-V5 antibody (middle panel). 
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Figure 6 
 
A. 
 
MIPFLPMFSL LLLLIVNPIN ANNHYDKILA HSRIRGRDQG PNVCALQQIL 
GTKKKYFSTC KNWYKKSICG QKTTVLYECC PGYMRMEGMK GCPAVLPIDH 100 
VYGTLGIVGA TTTQRYSDAS KLREEIEGKG SFTYFAPSNE AWDNLDSDIR  
RGLESNVNVE LLNALHSHMI NKRMLTKDLK NGMIIPSMYN NLGLFINHYP 200 
NGVVTVNCAR IIHGNQIATN GVVHVIDRVL TQIGTSIQDF IEAEDDLSSF 
RAAAITSDIL EALGRDGHFT LFAPTNEAFE KLPRGVLERI MGDKVASEAL 300 
MKYHILNTLQ CSESIMGGAV FETLEGNTIE IGCDGDSITV NGIKMVNKKD 
IVTNNGVIHL IDQVLIPDSA KQVIELAGKQ QTTFTDLVAQ LGLASALRPD 400 
GEYTLLAPVN NAFSDDTLSM DQRLLKLILQ NHILKVKVGL NELYNGQILE 
TIGGKQLRVF VYRTAVCIEN SCMEKGSKQG RNGAIHIFRE IIKPAEKSLH 500 
EKLKQDKRFS TFLSLLEAAD LKELLTQPGD WTLFVPTNDA FKGMTSEEKE 
ILIRDKNALQ NIILYHLTPG VFIGKGFEPG VTNILKTTQG SKIFLKEVND 600 
TLLVNELKSK ESDIMTTNGV IHVVDKLLYP ADTPVGNDQL LEILNKLIKY 
IQIKFVRGST FKEIPVTVYT TKIITKVVEP KIKVIEGSLQ PIIKTEGPTL 700 
TKVKIEGEPE FRLIKEGETI TEVIHGEPII KKYTKIIDGV PVEITEKETR 
EERIITGPEI KYTRISTGGG ETEETLKKLL QEEVTKVTKF IEGGDGHLFE 800 
DEEIKRLLQG DTPVRKLQAN KKVQGSRRRL REGRSQ 
 
B. 
MVPLLPLYAL LLLFLCDINP ANANSYYDKV LAHSRIRGRD QGPNVCALQQ 
ILGTKKKYFS SCKNWYQGAI CGKKTTVLYE CCPGYMRMEG MKGCPAVMPI 100 
DHVYGTLGIV GATTTQHYSD VSKLREEIEG KGSYTYFAPS NEAWENLDSD 
IRRGLENNVN VELLNALHSH MVNKRMLTKD LKHGMVIPSM YNNLGLFINH 200 
YPNGVVTVNC ARVIHGNQIA TNGVVHVIDR VLTQIGTSIQ DFLEAEDDLS 
SFRAAAITSD LLESLGRDGH FTLFAPTNEA FEKLPRGVLE RIMGDKVASE 300 
ALMKYHILNT LQCSEAITGG AVFETMEGNT IEIGCEGDSI SINGIKMVNK 
KDIVTKNGVI HLIDEVLIPD SAKQVIELAG KQQTTFTDLV AQLGLASSLK 400 
PDGEYTLLAP VNNAFSDDTL SMDQRLLKLI LQNHILKVKV GLSDLYNGQI 
LETIGGKQLR VFVYRTAICI ENSCMVRGSK QGRNGAIHIF REIIQPAEKS 500 
LHDKLRQDKR FSIFLSLLEA ADLKDLLTQP GDWTLFAPTN DAFKGMTSEE 
RELLIGDKNA LQNIILYHLT PGVYIGKGFE PGVTNILKTT QGSKIYLKGV 600 
NETLLVNELK SKESDIMTTN GVIHVVDKLL YPADIPVGND QLLELLNKLI  
KYIQIKFVRG STFKEIPMTV YRPAMTKIQI EGDPDFRLIK EGETVTEVIH 700 
GEPVIKKYTK IIDGVPVEIT EKQTREERII TGPEIKYTRI STGGGETGET 
LQKFLQKEVS KVTKFIEGGD GHLFEDEEIK RLLQGDTPAK KIPANKRVQG 800 
PRRRSREGRS Q 
 
1-23: Signal peptide 
42-89: EMI 
111-232: Fasciclin 1 
247-369: Fasciclin 2 
384-496: Fasciclin 3 
509-633: Fasciclin 4 
634-811: CTR 
	 36	
 
Figure 6. Protein sequences of human periostin and mouse periostin 
Isoform1. A. The human periostin has 3 probable S-X-E phosphorylation sites. B. 
There are five isoforms of the mouse periostin. The longest transcript mouse 
periostin isoform 1 which has 4 probable phosphorylation sites.(Coutu et al., 
2008). 
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